Do you believe you may be eligible for a Zantac cancer lawsuit? If you have been diagnosed with cancer after regularly taking the heartburn medication Zantac or a generic version, you should discuss your legal options with a knowledgeable Zantac cancer lawyer.
Zantac and generic heartburn medications containing ranitidine have been removed from the market because of concerns about high levels of probable cancer-causing impurities. You may have a right to file a ranitidine lawsuit and hold the drug manufacturer accountable.
The attorneys at Joye Law Firm are reviewing potential Zantac cancer lawsuit claims. Numerous Zantac lawsuits have been filed against the makers of medications containing ranitidine, and more lawsuits are expected.
More than 140 Zantac cancer lawsuits demanding compensation for injuries caused by ranitidine are filed as part of multidistrict litigation (MDL number 2924) in the U.S. District Court for the Southern District of Florida.
The lawsuits contend the manufacturer of Zantac and generic ranitidine heartburn medications knew or should have known that their medications exposed consumers to NDMA and elevated cancer risks. NDMA is a probable cause of cancer.
Our attorneys at Joye Law Firm are committed to helping South Carolinians who have been harmed by unsafe drugs and hold pharmaceutical companies fully responsible. We have been helping injured people in South Carolina stand up for their legal rights for more than 50 years.
We cannot guarantee any specific result in a Zantac cancer lawsuit. But our record of verdicts and settlements reflects the time and resources we put into each case and our experience handling complex product liability cases. Our law firm is honored by the testimonials of former clients.
Call us at 877-936-9707 to discuss your legal rights to file a ranitidine cancer lawsuit.
What is Zantac?
Zantac is a brand name medication that prevents and relieves symptoms of heartburn related to acid indigestion and gastroesophageal acid reflux disease (GERD). It acts to reduce the amount of acid in the stomach.
Zantac was developed by Glaxo, a company that is now part of GlaxoSmithKline PLC, and was introduced onto the market in 1983. It became a best-selling drug used by millions of Americans who suffered from heartburn and acid reflux.
Since 2017, the drug maker Sanofi-Aventis, U.S. has held the rights to sell over-the-counter Zantac in the U.S. Before that, Boehringer Ingelheim Pharmaceuticals, Inc., manufactured over-the-counter Zantac from 2006 to 2017.
Sanofi recently announced a voluntary recall of Zantac products in the United States.
What is Ranitidine?
Ranitidine is the active ingredient in Zantac and in generic over-the-counter and prescription versions of the medication. It is approved for treatment of ulcers in the stomach and treatment of GERD. Over-the-counter ranitidine is taken by consumers to relieve heartburn related to acid indigestion and sour stomach.
The lawsuit alleges the ranitidine molecule, the active ingredient in the medication, can break down over time and form the carcinogen NDMA.
The FDA has advised that consumers should stop taking any over-the-counter ranitidine products they currently have in their medicine cabinets. Patients taking prescription ranitidine should talk with their health provider about alternative treatment options before stopping the medicine. Multiple drugs are approved for similar uses as ranitidine.